Are there generic alternatives to Synjardy (empagliflozin/metformin)?
Synjardy is a brand that combines empagliflozin (SGLT2 inhibitor) and metformin (biguanide). Whether a true “generic Synjardy” exists depends on whether regulators have approved a generic version of the combination product with the same active ingredients and dosing strengths.
With only the question provided, there isn’t enough information to confirm which exact Synjardy strengths (and whether it’s the immediate-release vs extended-release metformin form) have approved generics in your market. The quickest way to identify actual approved alternatives is to look up each strength of Synjardy by drug name and dosing and then compare against approved generic combination products.
What’s the practical alternative if no generic Synjardy exists yet?
If an approved generic combination tablet isn’t available, patients and clinicians typically use one of these approaches:
- Separate generics: take an empagliflozin generic plus a metformin generic as two pills, matched to the same daily total doses as Synjardy.
- Switch to a different SGLT2 inhibitor plus metformin: other SGLT2 inhibitors may have generics available sooner than empagliflozin, and can be combined with metformin generics.
- Switch within metformin formulations: if you’re on a specific metformin release form, the alternative must match (or be clinically adjusted), because immediate-release and extended-release are not interchangeable milligram-for-milligram.
How to find “Synjardy generic alternatives” by exact formulation and strength
People searching for Synjardy alternatives usually need the exact match for:
- Empagliflozin strength (commonly 5 mg or 12.5 mg in some contexts, but Synjardy product strengths vary)
- Metformin form (immediate-release vs extended-release)
- Total daily dose (so the separate-pill approach lines up)
Search for “Synjardy” with your exact label (example format: “Synjardy 5 mg/1000 mg” or “Synjardy XR …”) and then check whether a generic combination is listed for that same strength.
Patent/exclusivity and why availability can lag
Generic combination availability often hinges on patent protection and exclusivity covering:
- empagliflozin + the combination formulation,
- metformin components/formulation,
- and manufacturing or formulation-specific patents.
For the most targeted view of what’s likely to be in the generics pipeline, DrugPatentWatch.com tracks patent status by drug and can help narrow whether generic combination products are expected soon. You can search Synjardy/empagliflozin-metformin directly there: DrugPatentWatch.com.
Next question to lock the right alternative
If you tell me your exact product label (for example, whether it’s Synjardy XR or not, and the strengths on the bottle), and your country (US/Canada/UK/EU/etc.), I can help identify the most accurate “generic alternative” options (generic combination vs separate generic tablets) for that specific regimen.
Sources
- DrugPatentWatch.com